Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Colorcon
Mallinckrodt
Express Scripts
McKinsey

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Methenamine hippurate - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Drug Prices for methenamine hippurate

See drug prices for methenamine hippurate

Recent Clinical Trials for methenamine hippurate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Göteborg UniversityPhase 4
VU University Medical CenterPhase 4
Medical Universtity of LodzPhase 4

See all methenamine hippurate clinical trials

Medical Subject Heading (MeSH) Categories for methenamine hippurate
Synonyms for methenamine hippurate
1,3,5,7-Tetraazatricyclo[3.3.1.13,7]decane N-Benzoylglycine
5714-73-8
714M738
AC1L2JF7
API0009010
C9H9NO3.C6H12N4
CHEBI:6825
CHEMBL1201104
D00855
EINECS 227-206-5
FT-0671059
Glycine, N-benzoyl, compd. with 1,3,5,7-tetraazatricyclo(3.3.1.1(sup 3,7))decane (1:1)
Haiprex
Hexamethylene tetramine hippurate
Hexamethylenetetramine hippurate
Hexamethylenetetramine Hippuric Acid Complex
Hexamethylenetetramine monohippurate
Hexamethylenetetramine monohippurate;Hexamethylenetetramine monohippurate
hexamine hippurate
Hippramine
HIPPURIC ACID, compd. with HEXAMETHYLENETETRAMINE (1:1)
Hiprex
Hiprex (TN)
LS-75816
M329791L57
METHENAMINE HIPPURATE (200 MG)
Methenamine hippurate (JAN/USP)
Methenamine hippurate [USAN:USP:INN:BAN]
Methenamine hippurate [USAN]
N-Benzoylglycine, compound with 1,3,5,7-tetraazatricyclo(3.3.1.13,7)decane (1:1)
R-657
SCHEMBL3029
UNII-M329791L57
Viapta

US Patents and Regulatory Information for methenamine hippurate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Micro Labs METHENAMINE HIPPURATE methenamine hippurate TABLET;ORAL 212172-001 Aug 1, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma Ltd METHENAMINE HIPPURATE methenamine hippurate TABLET;ORAL 205661-001 Jul 5, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Cnty Line Pharms UREX methenamine hippurate TABLET;ORAL 016151-001 Approved Prior to Jan 1, 1982 AB RX No No   Start Trial   Start Trial   Start Trial
Us Pharm Holdings HIPREX methenamine hippurate TABLET;ORAL 017681-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Impax Labs Inc METHENAMINE HIPPURATE methenamine hippurate TABLET;ORAL 076411-001 Jun 20, 2003 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Mallinckrodt
McKinsey
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.